These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8476089)

  • 1. Effects of corticotropin-releasing factor on isolated rat heart activity.
    Grunt M; Glaser J; Schmidhuber H; Pauschinger P; Born J
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1124-9. PubMed ID: 8476089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of corticotropin releasing factor on atrial natriuretic peptide release from the isolated perfused rat heart.
    Haug C; Grunt M; Schmid S; Steinbach G; Metzele A; Maier V; Keck FS; Grünert A
    Arzneimittelforschung; 1994 May; 44(5):579-82. PubMed ID: 8024626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release.
    Grunt M; Haug C; Duntas L; Pauschinger P; Maier V; Pfeiffer EF
    Horm Metab Res; 1992 Feb; 24(2):56-9. PubMed ID: 1533382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart.
    Terui K; Higashiyama A; Horiba N; Furukawa KI; Motomura S; Suda T
    J Endocrinol; 2001 Apr; 169(1):177-83. PubMed ID: 11250659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.
    Barker DM; Corder R
    Br J Pharmacol; 1999 Jan; 126(1):317-25. PubMed ID: 10051151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
    Karanth S; Lyson K; McCann SM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3383-7. PubMed ID: 8475085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilation of rat diaphragmatic arterioles by flow and hypoxia: roles of nitric oxide and prostaglandins.
    Ward ME
    J Appl Physiol (1985); 1999 May; 86(5):1644-50. PubMed ID: 10233130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EDRF and norepinephrine-induced vasodilation in the canine coronary circulation.
    Van Bibber R; Traub O; Kroll K; Feigl EO
    Am J Physiol; 1995 May; 268(5 Pt 2):H1973-81. PubMed ID: 7771547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in hypoxic coronary vasodilatation in isolated perfused guinea pig heart.
    Brown IP; Thompson CI; Belloni FL
    Am J Physiol; 1993 Mar; 264(3 Pt 2):H821-9. PubMed ID: 8456983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1 beta.
    Sandi C; Guaza C
    Eur J Pharmacol; 1995 Feb; 274(1-3):17-23. PubMed ID: 7768270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat.
    Lee EH; Lee CP; Wang HI; Lin WR
    Synapse; 1993 Jun; 14(2):144-53. PubMed ID: 7687386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of indomethacin and N omega-nitro-L-arginine methyl ester on the pressure/flow relation in isolated perfused hindlimbs from pregnant and nonpregnant rats.
    Ahokas RA; Friedman SA; Sibai BM
    J Soc Gynecol Investig; 1997; 4(5):229-35. PubMed ID: 9360226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery.
    Jain V; Vedernikov YP; Saade GR; Chwalisz K; Garfield RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):407-13. PubMed ID: 9918539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
    Raber J; Koob GF; Bloom FE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent.
    Grossini E; Molinari C; Mary DA; Marino P; Vacca G
    Eur J Pharmacol; 2008 Jan; 578(2-3):242-8. PubMed ID: 17936748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus.
    Page ME; Abercrombie ED
    Synapse; 1999 Sep; 33(4):304-13. PubMed ID: 10421711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide modulates hepatic vascular tone in normal rat liver.
    Mittal MK; Gupta TK; Lee FY; Sieber CC; Groszmann RJ
    Am J Physiol; 1994 Sep; 267(3 Pt 1):G416-22. PubMed ID: 7943239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation.
    McQueston JA; Cornfield DN; McMurtry IF; Abman SH
    Am J Physiol; 1993 Mar; 264(3 Pt 2):H865-71. PubMed ID: 8456989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin-induced relaxation in the human internal mammary artery.
    Chen ZW; Huang Y; Yang Q; Li X; Wei W; He GW
    Cardiovasc Res; 2005 Mar; 65(4):913-20. PubMed ID: 15721872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.